TrialThe Journal of infectious diseases2024

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032.

Kristina M Brooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.